Earlier today, ObvioHealth posted content on its website about how digital instruments are transforming electronic patient-reported results in clinical trials. The post touches on a variety of points, from the accuracy of trial evaluation criteria to how these digital instruments are improving the landscape of decentralized trials.
Accurate clinical trial endpoints require reliable, high-quality patient-reported results. The same goes for decentralized clinical trials (DCTs). In fact, the digital and virtual components that define DCTs are highly dependent on the direct input and engagement of participants, so much so that it is essential to continuously optimize the data collection process to ensure that the results electronic patient-reported (ePRO) results in clinically validated results. .
Digital instruments are changing electronic patient-reported outcomes in the DCT landscape. Accessible to patients, these tools improve data quality, simplify data collection, and reduce participant burden, allowing researchers to collect more real-time data than ever before.
Although intensified by the global health crisis, the transition to DCTs has been happening for years. However, many clinical studies are still conducted using traditional methods: clinicians collect patient data on the spot, often using paper questionnaires and in-person interviews.
Although this strategy builds trust between patients and therapists, it is not without flaws. Patients, being human, delay treatment. They finish their essay assignments or fill their diary at the last minute, which impairs their ability to accurately remember essential details.
People are also more likely to be performative when they feel like they are on display or in place, reflecting for an audience what they have accomplished or failed to accomplish. Participants may be reluctant to reveal their actual activities and instead report what they think researchers want to hear. Consider how simple it is to under-report the number of cocktails you drink per week or to exaggerate how often you brush your teeth.
Over the next few years, the optimization of electronic patient-reported outcomes will drive increased use of DCTs and hybrid trials, allowing sponsors and contract research companies to optimize data collection and integrity. However, despite the fact that DCTs have opened the floodgates to data, more data is not the end goal; test teams need to generate better data.
To learn more about ObvioHealth or to read its article, visit the following URL: https://www.obviohealth.com/
Name: James Hendrick
Email: Send email
Organization: ObvioHealth USA, Inc.
Address: 3452 Lake Lynda Drive Suite 151, Orlando, Florida 32817, USA
Build ID: 89076907
If you detect any problems, problems or errors in the content of this press release, please contact [email protected] to let us know. We will respond and rectify the situation within the next 8 hours.